Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
about
Ketamine and other glutamate receptor modulators for depression in adultsPotential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsA systematic review for the antidepressant effects of sleep deprivation with repetitive transcranial magnetic stimulationDelineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systemsThe role of ketamine in treatment-resistant depression: a systematic review.Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study.Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the ratAMPA Receptor-mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role.A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.Abnormal levels of seven amino neurotransmitters in depressed rat brain and determination by HPLC-FLD.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Neurochemical alterations in frontal cortex of the rat after one week of hypobaric hypoxiaON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression.Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials.Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?The organization of the stress system and its dysregulation in depressive illness.Issues encountered in recent attempts to develop novel antidepressant agents.Genome-wide association studies in pharmacogenomics of antidepressants.New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Targeting glutamate signalling in depression: progress and prospects.Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionEnhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.An astroglial basis of major depressive disorder? An overview.Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.Two grams of sarcosine in schizophrenia - is it too much? A potential role of glutamate-serotonin interaction.Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia.Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.Glycine Transporters and Its Coupling with NMDA Receptors.Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?Beyond Ketamine: New Approaches to the Development of Safer Antidepressants.Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression.Glutamatergic Modulators in Depression.Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.Convergent Mechanisms Underlying Rapid Antidepressant Action.D-Serine in Neuropsychiatric Disorders: New Advances
P2860
Q24186746-7C42FFB1-EEE9-4E5B-8853-150DC40F028BQ26782274-9C899E20-19B9-4579-BC21-08CD74EE27F6Q27024249-6D24A464-9230-407D-819D-14B7486F453BQ33635613-BC9FC64F-3B3D-4CD6-B546-429B05088D29Q34449588-2CA9EB2B-B288-442B-AB98-5C730E272152Q35167939-0D89FBD9-3A5C-4656-8461-9166E6EEE82EQ35179053-8F5C9C1E-5047-4089-8D8C-9892B7D8C32DQ35753372-AD44BACD-CCDB-4ADC-8167-7B671DD288B2Q35958805-27427ABC-D958-4E2C-B59B-4C85C1BCE72CQ36252228-147054DF-8B3C-47DE-952F-65B8266A6948Q36310524-924082B5-28C4-42AE-9A56-E81BD1437040Q36424593-64D5AA74-34CD-40F2-B1C6-110ADAE2072CQ37583961-A6805446-1AB8-4099-A40C-44758B5B2EFDQ37673343-024F3E82-7FD1-4495-8F51-7316D7FE3686Q37741989-C2BCE7A9-0CB1-48A6-BDEA-CE4504C5AB6AQ38227967-1A61C53C-5EA9-4EC8-A55B-7B45F6EBFE8AQ38254452-321EB417-D40E-424A-B4E1-9717A62A720FQ38285276-6FD7580D-6583-4022-AB50-B369F4409131Q38374429-05D6317E-16D6-44B2-AFD5-3BDD3542FD84Q38444447-E9B3E78E-383A-44D6-AFAB-7DA3DF231910Q38685420-544B6530-E651-4FA0-89DA-AC6B2067C24DQ38743867-7A94CBB8-AD51-4CE3-A001-DA30F9DA8581Q38839164-A3BF27F2-04FB-4A54-9239-1AE86EC08711Q38990885-F7B7051D-767F-4850-AD3D-7124BE8EDEC4Q39121207-C5E2C46E-0A07-4A07-A4D4-F7289E39FEBEQ39186841-7BB0BA5A-C1ED-4B61-8421-8EF2C6C2C2E8Q39261780-8C564A95-76B0-4A08-9EC8-E6DFE0A3A0AEQ41945244-ACD83F56-D38C-4447-AD33-84A6DF9D05E9Q45386926-01890954-A708-4F2F-96FE-2551EFFB8BD4Q47414662-0B20D61E-BFE5-478A-B733-67ECF9A1BAFDQ47791708-19CC36B6-97E0-4901-9D28-5EE5F5DE01BDQ47805452-4E5300D2-9E78-4ED9-83A8-60A20810381FQ47963007-CD2904D6-5457-4D4A-A1F9-2BCC1DD86A7BQ48137942-99EA4B73-63C7-4E32-A94E-44EC2CFDFF15Q49712849-6E6AFE79-355A-4D46-9723-FFE838D4F91AQ49829601-F38A8F71-FBF8-410A-951C-47D1C317BFD7Q50591774-FA2CE01B-CB6B-4738-9339-2323BE166C0EQ52667723-657FE0AC-BC6B-4D0B-8F5E-5BCC652DDE11Q59052088-87952A60-37F8-4FE1-A31B-0CA7CEA7CB3F
P2860
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@ast
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@en
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@nl
type
label
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@ast
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@en
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@nl
prefLabel
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@ast
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@en
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@nl
P2093
P1476
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
@en
P2093
Chieh-Liang Huang
Chih-Chia Huang
Guochuan Emil Tsai
Hsien-Yuan Lane
Kuang-Ti Chen
Kuo-Hao Huang
Mang-Hung Tsai
Priscilla Tsai
P304
P356
10.1016/J.BIOPSYCH.2013.02.020
P407
P577
2013-04-03T00:00:00Z